Higher Demand for Breast Biopsy and Devices Market in Healthcare Industry with Comprehensive Insight

The Breast Biopsy Device Market Research Report Forecast 2012-2022 is a valuable source of insightful data for business strategists. It provides the Breast Biopsy Device industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis.

Download PDF Brochure of this Report: http://www.crystalmarketresearch.com/pdfdownload/CM10250

The Breast Biopsy Device Market was worth USD 0.38 billion in the year 2012 and is expected to reach approximately USD 1.03 billion by 2022, while registering itself at a significant compound annual growth rate (CAGR) of 9.39% during the forecast period. It is a diagnostic method that includes the expulsion of fluid or tissue from a suspicious region. The test needs working with guidance systems, the intent behind which is to detect an abnormality or a lump from the breast area. The varied modalities utilized as controlling systems in the location of breast tumors incorporate the ultrasound, mammography, and magnetic resonance imaging. The ultrasound section is foreseen to witness the quickest development attributable to the increasing requirement of non-radiation biopsies alongside the increasing interest for minimally invasive techniques.

Key Market Players:

• Devicor Medicals Products Inc
• C. R. Bard Inc.
• OncoCyte Corporation
• Stryker International Inc.
• Dickinson and Company (BD)
• F. Hoffmann-La Roche Ltd.
• Hologic Inc
• Laboratory Corporation of America Holdings

The expansion in the recurrence of breast cancers in women worldwide, and in addition the ascent in awareness of cancer screening programs is a portion of the components that are assessed to add to the market development over the gauged time frame. Furthermore, the various kinds of product improvement, ceaselessly propelled in the market are additionally anticipated that would positively affect this industry amid the estimated time frame. For example, C.R Bard's Mission Truguide disposable coaxial biopsy needles, made of ultrathin walls, give high effectiveness and precision in the securing of sample tissue. Nonetheless, the dangers engaged with the methodology are probably going to influence the Breast Biopsy Device Market contrarily. The level of hazard considers the invasiveness of the method utilized. Surgical core methods may be more precise and successful however it includes real dangers. Besides, roughly 60%to 80% of the biopsies acquired are generous. Subsequently, women are urged to take a second opinion before experiencing any such surgical strategies, which thusly is relied upon to contrarily influence the market development.

The key products utilized for breast biopsy are guidance systems, localization wires, biopsy tables and needles among others. In 2015, the needles segment possessed a major share. This development is accountable to its wide relevance in the needle breast biopsy market. A large portion of the developments and progressions are seen in the products section. For example, the Stryker PreciseCore needle lets sample collection with higher accuracy and with far less risks of tissue damage included. Moreover, the guidance system product section is foreseen to witness a high development rate amid the projected time frame. In needles, the fine needle aspiration makes use of a very small needle to remove cells or liquid from the abnormal part and the core needle make the use of a big hollow needle to extract one sample of the breast in every insertion. In localization wires a guide wire is put into the suspicious part to assist the surgeon to detect the lesion for surgical biopsy.

Get sample copy of this Report: http://www.crystalmarketresearch.com/report-sample/CM10250

The biopsy methods require guidance systems to find the irregularity or lumps in the breast area. The accessible guiding systems utilized for biopsies incorporate the magnetic resonance guided biopsies, ultrasound-guided, and mammography-guided stereotactic among others that guide with the technique in identifying and finding the existence of unusual cell developments. The mammography-guided portion adds to the biggest share in the industry. Nonetheless, the likelihood of false positive outcomes related with the imaging of breast tissues that are dense is generally high. The ultrasound-guided method yields more exact outcomes and is foreseen to witness the most striking development rate amid the forecast period.

North America is accountable for a bigger market share, primarily due to existence of key market players and prompts adoption of enhanced medical technologies, especially in countries like Canada and the U.S. According to a non-profit organization which emphasizes on breast cancer awareness – Susang Komen, in 2015 there were more than 2.3 million breast cancer cases that were diagnosed in the United States alone. Asia Pacific region is anticipated to gain lucrative market during the forecast period. This is due to the increased level of awareness amongst the population, rising disposable income, and large population. International Association of Cancer Registries stated that in 2012, more than 600,000 fresh cases of breast cancer were diagnosed in Asia and that accounted for 39% of overall breast cancers diagnosed across the world. In EU-28 of The European Breast Cancer Coalition, it has been stated that in 2012, 361,600 breast cancer cases were registered. Also, one in every eight women in the EU-28 is expected to acquire breast cancer before the age of 85.

Buy key industry insights spread across 127 pages with 111 market data tables & 25 figures & charts from the report Breast Biopsy Device Market in detail along with the table of contents.

Buy Report: http://www.crystalmarketresearch.com/checkout/CM10250

About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:

Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
Blog: blog.crystalmarketresearch.com
Website: www.crystalmarketresearch.com

This release was published on openPR.